2025 third_quarter Filing
Q3Expenses
$130K
Method: A
Filed
October 27, 2025
Lobbying Activities
Health IssuesView all
Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA
Contacted:HOUSE OF REPRESENTATIVES, SENATE
DefenseView all
Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Disaster Planning/Emergencies
Lobbyists (1)
LAURA EFROS